Thanks FM. I’m still learning but I’m pretty sure you could meta-analyze more than 20 biased studies and you still get bias. Exhibit A: HRT in post menopausal women https://t.co/ITut1AoHmK https://t.co/CYRmzy6ehM
Hormone therapy to prevent disease and prolong life in postmenopausal women.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2023 – Mar 2024Where it's discussed
-
News15 articles
-
X / Twitter4 posts
-
Blogs4 articles
-
YouTube2 videos
AI synopsis
What people are saying
The discussions reveal a focus on the challenges of synthesizing observational studies about hormone therapy, exemplified by remarks such as 'Bias x Bias still equals bias' and references to meta-analysis limitations, emphasizing scientific skepticism and cautious interpretation rather than immediate clinical implications. The tone underscores a critical, analytical approach to evaluating the published research.
Posts demonstrate caution about the validity of meta-analyses, showing some agreement that bias complicates interpretations.
Discussions show moderate interest, focusing on methodological challenges rather than the direct implications of hormone therapy.
Comments suggest thoughtful consideration and critical engagement with the topic, referencing studies and meta-analysis concepts.
The discussion raises awareness about research limitations but does not directly influence clinical practice or policy debates yet.
Abstract in brief
- The review examines the risks and benefits of hormone therapy (estrogen alone or with progestin) for postmenopausal women considering long-term use to prevent disease or extend life, highlighting benefits like reduced risk of coronary heart disease and hip fractures, but also increased risks of endometrial and possibly breast cancer.
- The study uses meta-analysis and lifetable methods to estimate how hormone therapy influences lifetime disease probabilities and life expectancy, finding that adding progestin can mitigate endometrial cancer risk in women with uteri, though the effects on other diseases are not well understood.
- The authors suggest hormone therapy may be advisable for women who have had a hysterectomy or are at high risk of coronary heart disease, but the optimal approach for other women remains uncertain due to unresolved safety questions.
Top posts
Most liked on X and Bluesky@DrBendary Me too. But even meta-analyzing observational studies seems tough. Bias x Bias still equals bias -- see Grady et al. https://t.co/czMnSqFjMH
RT @drjohnm: Thanks FM. I’m still learning but I’m pretty sure you could meta-analyze more than 20 biased studies and you still get bias.…
RT @drjohnm: Thanks FM. I’m still learning but I’m pretty sure you could meta-analyze more than 20 biased studies and you still get bias.…
All mentions
Latest Insights on Cardiology and the MIND Diet Trial Findings
This podcast discusses listener feedback on conduction system pacing and examines a trial on the MIND diet. The study investigates the MIND diet's effectiveness in preventing cognitive decline in older adults, measuring…
Advances in Atrial Fibrillation Treatment and Hormone Therapy in Postmenopausal Women
This week in cardiology, focusing on AF conversion with IV potassium and magnesium in emergency cases, and reviewing hormone therapy's risks and benefits for postmenopausal women, including disease prevention and life…
@DrBendary Me too. But even meta-analyzing observational studies seems tough. Bias x Bias still equals bias -- see Grady et al. https://t.co/czMnSqFjMH
RT @drjohnm: Thanks FM. I’m still learning but I’m pretty sure you could meta-analyze more than 20 biased studies and you still get bias.…
RT @drjohnm: Thanks FM. I’m still learning but I’m pretty sure you could meta-analyze more than 20 biased studies and you still get bias.…
Thanks FM. I’m still learning but I’m pretty sure you could meta-analyze more than 20 biased studies and you still get bias. Exhibit A: HRT in post menopausal women https://t.co/ITut1AoHmK https://t.co/CYRmzy6ehM
JM
BF
CA